# Gum Arabic Modulates Redox–Ionic Microenvironments via Rheology and Kinetics to Induce Selective Cytotoxicity in Colorectal Cancer Cells

**Authors:** Emre Cebeci, Büşra Yüksel, Reyhan Aliusta, Şahin Yılmaz, Ertuğrul Osman Bursalıoğlu, Mustafa Eray Bozyel, Halise Betül Gökçe, Şaban Kalay, Şükran Özdatlı Kurtuluş, Ahmet Arif Kurt, Fikrettin Şahin, Ismail Aslan

PMC · DOI: 10.3390/gels12020139 · 2026-02-03

## TL;DR

Gum Arabic acts as a natural gel that selectively harms colorectal cancer cells by altering their redox and ionic environment.

## Contribution

The study reveals how Gum Arabic's rheological and kinetic properties contribute to its selective cytotoxicity in colorectal cancer cells.

## Key findings

- Gum Arabic showed dose-dependent cytotoxicity in cancer cells but not in normal fibroblasts.
- Rheological analysis identified a 10% GA formulation as optimal for viscoelastic properties.
- GA treatment increased Fe2+, Zn2+, and Mn2+ levels, modulating the redox-ionic microenvironment.

## Abstract

Background: Gum Arabic (GA) is a natural polysaccharide widely recognized for its antioxidant and anti-inflammatory properties; however, its functional behavior as a biopolymeric gel and the mechanisms underlying its selective effects on cancer-related redox microenvironments remain insufficiently characterized. It is imperative to note that the interaction between its physicochemical properties and its biological activity in colorectal cancer remains to be fully clarified. Methods: This study aimed to evaluate the antineoplastic potential of GA in human colorectal cancer (CRC) cell lines (HT-29 and HCT-116) compared to normal fibroblasts (MRC-5) using the MTS assay. Oxidative stress-related molecular responses were assessed by quantitative PCR analysis of GPX4, GSTA2, CAT, NFKB, and SOD1 expression. In parallel, extracellular concentrations of key metal ions (Fe2+, Zn2+, Mn2+, Mg2+, Cu2+, and Al3+) were quantified following GA exposure. To establish its functional gel characteristics, rheological measurements were performed to assess viscosity and shear-dependent behavior, and USP-compliant in vitro kinetic studies were conducted to evaluate time-dependent release properties. Results: GA induced dose-dependent cytotoxicity in HT-29 and HCT-116 colorectal cancer cells, while MRC-5 fibroblasts exhibited comparatively higher viability across the tested concentration range, indicating reduced sensitivity in normal cells. Rheological analysis revealed concentration- and ion-dependent viscoelastic behavior, identifying a 10% (w/w) GA formulation as optimal due to its balanced low-shear viscosity and controlled shear-thinning properties. Kinetic studies demonstrated a defined, diffusion-governed release profile under physiologically relevant conditions. At the molecular level, significant upregulation of GPX4 and GSTA2 was observed in both cancer cell lines, whereas NFKB expression increased selectively in HT-29 cells, with no notable changes in CAT or SOD1 expression. Additionally, GA treatment resulted in marked increases in Fe2+, Zn2+, and Mn2+ levels, indicating modulation of the redox–ionic microenvironment. Conclusions: These findings demonstrate that GA functions as a natural, ion-responsive biopolymeric system with defined rheological and kinetic properties, capable of selectively targeting colorectal cancer cells through coordinated genetic and ionic regulation of oxidative stress. Collectively, the results position GA as a promising functional gel-based platform for future redox-modulated therapeutic strategies in colorectal cancer.

## Linked entities

- **Genes:** GPX4 (glutathione peroxidase 4) [NCBI Gene 2879], GSTA2 (glutathione S-transferase alpha 2) [NCBI Gene 2939], CAT (catalase) [NCBI Gene 847], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790], SOD1 (superoxide dismutase 1) [NCBI Gene 6647]
- **Chemicals:** Fe2+ (PubChem CID 23925), Zn2+ (PubChem CID 32051), Mn2+ (PubChem CID 27854), Mg2+ (PubChem CID 888), Cu2+ (PubChem CID 27099), Al3+ (PubChem CID 104727)
- **Diseases:** colorectal cancer (MONDO:0005575)

## Full-text entities

- **Genes:** GPX4 (glutathione peroxidase 4) [NCBI Gene 2879] {aka GPx-4, GSHPx-4, MCSP, PHGPx, SMDS, snGPx}, RPL30 (ribosomal protein L30) [NCBI Gene 6156] {aka L30, eL30}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}, KRAS (KRAS proto-oncogene, GTPase) [NCBI Gene 3845] {aka 'C-K-RAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A}, GSTA2 (glutathione S-transferase alpha 2) [NCBI Gene 2939] {aka GST2, GSTA2-2, GTA2, GTH2}, CAT (catalase) [NCBI Gene 847], COL4A4 (collagen type IV alpha 4 chain) [NCBI Gene 1286] {aka ATS2, BFH, BFH1, CA44}, BRAF (B-Raf proto-oncogene, serine/threonine kinase) [NCBI Gene 673] {aka B-RAF1, B-raf, BRAF-1, BRAF1, NS7, RAFB1}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** liver (MESH:D017093), colorectal tumorigenesis (MESH:D063646), CRC (MESH:D015179), deaths (MESH:D003643), cervical cancer (MESH:D002583), obesity (MESH:D009765), breast and liver cancer (MESH:D001943), microbial infections (MESH:D015163), prostate cancer (MESH:D011471), breast, pancreatic, and prostate cancer (MESH:C537243), glioma (MESH:D005910), inflammatory (MESH:D007249), injury to (MESH:D014947), brain tumors (MESH:D001932), colorectal adenocarcinoma (MESH:D003110), Cytotoxicity (MESH:D064420), Cancer (MESH:D009369), diabetes (MESH:D003920), liver cancer (MESH:D006528)
- **Chemicals:** polypropylene (MESH:D011126), Gallic acid (MESH:D005707), Zn (MESH:D015032), penicillin (MESH:D010406), oxygen (MESH:D010100), sodium alginate (MESH:D000464), K+ (MESH:D011188), lipid (MESH:D008055), Fe (MESH:D007501), salts (MESH:D012492), silica (MESH:D012822), doxorubicin (MESH:D004317), imatinib mesylate (MESH:D000068877), sugars (MESH:D000073893), Gold (MESH:D006046), curcumin (MESH:D003474), glutathione (MESH:D005978), CO2 (MESH:D002245), water (MESH:D014867), 5-fluorouracil (MESH:D005472), superoxide (MESH:D013481), Metal (MESH:D008670), K39 (-), zinc oxide (MESH:D015034), hydrogen peroxide (MESH:D006861), selenium (MESH:D012643), calcium (MESH:D002118), pyrimidine (MESH:C030986), aldehyde (MESH:D000447), heavy metal (MESH:D019216), hyaluronic acid (MESH:D006820), polymer (MESH:D011108), folic acid (MESH:D005492), ROS (MESH:D017382), streptomycin (MESH:D013307), Arabic gum (MESH:D006170), Pip (MESH:C008922), hydroxyapatite (MESH:D017886), magnesium (MESH:D008274), oxaliplatin (MESH:D000077150), D-glucose (MESH:D005947), irinotecan (MESH:D000077146), alcohols (MESH:D000438), copper (MESH:D003300), alkaloid (MESH:D000470), cellulose acetate (MESH:C005062), PBS (MESH:D007854), arabinogalactan (MESH:C005653), silver (MESH:D012834), polyols (MESH:C024617), graphene oxide (MESH:C000628730), amphotericin (MESH:D000666), resveratrol (MESH:D000077185), polysaccharide (MESH:D011134), Iron oxide (MESH:C000499)
- **Species:** Senegalia senegal (gum-arabic, species) [taxon 138043], Vachellia seyal (species) [taxon 138044], Vachellia nilotica (babul, species) [taxon 138033], Homo sapiens (human, species) [taxon 9606], Yucca filamentosa (Adam's needle and thread, species) [taxon 55960]
- **Cell lines:** HCT-116 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_0291), HepG2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027), MRC-5 — Homo sapiens (Human), Finite cell line (CVCL_0440), HTB-38 — Mus musculus (Mouse), Hybridoma (CVCL_A8FQ), CRL-171 — Sigmodon hispidus (Hispid cotton rat), Spontaneously immortalized cell line (CVCL_YD58), HT-29 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0320)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940207/full.md

---
Source: https://tomesphere.com/paper/PMC12940207